BPC-157: what the pentadecapeptide is and what studies examine

BPC-157 is a synthetic peptide fifteen amino acids long, which is why it is often called a pentadecapeptide. Its sequence corresponds to a fragment first identified inside a larger protein found in gastric tissue, though the material used at the bench is made from scratch rather than extracted. Supplied as an isolated, well-characterized molecule with stable physicochemical properties, it is something US researchers reach for routinely across biochemical, cell-based and preclinical work.

For laboratory research only. BPC-157 is sold exclusively for in-vitro research. Nothing on this page covers dosing, administration or use in people or animals, no therapeutic claims are made or implied, and the compound has not been evaluated by the FDA.

What BPC-157 is

The name encodes the chemistry. Pentadeca means fifteen, so a pentadecapeptide is a fifteen-residue chain. BPC is short for "body protection compound," the label given to the parent protein fragment its sequence was drawn from. Two things follow from its size. First, a fifteen-residue peptide is straightforward to synthesize and to verify analytically, which is part of why it is so widely used as a research tool. Second, it is small and stable enough to behave predictably in solution, so it serves well as a probe for short-peptide signaling rather than as a finished answer to any biological question. If you are new to the category, what research peptides are is the place to start.

What the research actually examines

Across biochemical and cell-based studies, BPC-157 has been reported to interact with a handful of signaling pathways, among them nitric-oxide-related processes, growth-factor signaling and regulators of cytoskeletal dynamics. It is worth being precise about what that means, because searches return a great many confident benefit lists that the primary literature does not support.

The published work is in-vitro and preclinical: cultured cells, ex-vivo tissue and animal models. What those studies find shifts a great deal with the model system, the concentration used, how long cells are exposed, and the method applied. A systematic review of the BPC-157 literature (cited below) is a useful map of what has and has not been studied, and the short version is that the compound is interesting as a mechanistic probe, not as a demonstrated outcome in people. Common uses at the bench include:

• Mechanistic studies in preclinical or ex-vivo models
• Probing short-peptide signaling mechanisms in vitro
• Examining nitric-oxide-associated and growth-factor-related pathways
• Looking at cytoskeletal organization and cell-matrix interaction behavior

Supply and format

We ship BPC-157 as a pre-mixed solution rather than a lyophilized powder, so there is no reconstitution step and no preparation variability to introduce. Each batch is documented by its own Certificate of Analysis: purity by HPLC, identity confirmed by mass spectrometry. Recent certificates sit in the COA library, and the peptide calculator handles concentration arithmetic if you are working from the vial. Keep it refrigerated at 2-8°C, not frozen, to hold stability.

How BPC-157 ships in the United States

For US laboratories, BPC-157 is supplied as a pre-mixed solution at 99%+ HPLC-verified purity, with a batch-specific Certificate of Analysis covering purity by HPLC and identity by mass spectrometry. Every batch is synthesized in our own UK laboratory, and each US lot is verified in a US laboratory before it ships, so what arrives is made in one place and checked again close to you. Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day, priced in US dollars and payable by Visa, Mastercard or Apple Pay. Store it refrigerated at 2-8°C on arrival, not frozen.

BPC-157 in multi-compound research sets

The same peptide turns up in several pre-combined research sets, where it is studied next to other peptides under one set of conditions: the Glow Stack, the Wolverine Stack and the Klow Stack. These blends fix the ratio of their components in one characterized vial, which removes the variability of preparing several solutions, but they cannot tell you which component produced an observed effect. That is why serious protocols usually run the single compound as well. The Glow Stack guide covers the combined-formulation angle.

What BPC-157 is not

• It is not an approved medicine in the United States or anywhere else, has not been evaluated by the FDA, and is not supplied for human or veterinary use.
• It is not a proven therapy. The benefit claims that circulate online run well past the in-vitro and preclinical evidence.
• It is not a natural extract. The research material is synthesized to a defined sequence, not purified from tissue.

Dosing and administration

We do not publish dosing, reconstitution-for-use or administration guidance for BPC-157. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, so quantity guidance aimed at a person would be inconsistent with what is supplied. Experimental concentrations depend on the model and endpoint and belong in the primary literature.

Where to read next

• New to the category? Begin with what research peptides are.
• Want the combined-formulation angle? See what the Glow Stack is.